PharmiWeb.com - Global Pharma News & Resources

Events

Featured Events

Events

26-Feb-2024 - 28-Feb-2024
Driving Innovation in Discovery and Chemistry, Validating Clinical Proof-of Concept and Streamlining CMC of Conjugates with Novel Payloads and FormatsTraditional ADCs have seen significant success in recent years, but still face many challenges, from limited payload capacities to significant toxicities. Given these limitations, drug developers are venturing beyond the conventional boundaries of conjugate drug design, by exploring novel payloads and targeting formats, with companies including VincerX Pharma, Dyne Therapeutics, and Orum Therapeutics currently awaiting clinical validation. Join 150+ of your peers to share learnings and collaborate on novel design concepts, key translational and clinical development challenges, and address challenging CMC roadblocks for the next generation of…
3rd Next-Generation Conjugates Summit
26-Feb-2024 - 27-Feb-2024

TBC, Nice, Nice, Nice, Provence-Alpes-Côte d'Azur, France

The aim of this course is to provide attendees with a good basis to work from when involved in taking development candidates to the first in human trials with a view also on some longer-term requirements. The course content will therefore focus on the necessary early phases of chemical development as would typically be required to support production of up to about 2kg using laboratory-based 20L equipment and pilot plant equipment. The course will introduce and discuss the following: > Requirements in order to move from small (<1g) supplies to the first 100g or so for preclinical work> Further scaling to 1-2kgs non-cGMP> Requirements to make material for use in clinical trial - an introduction to cGMP coupled with the scaling issues> An overview of the requirements to move pr…
MOLECULE TO MEDICINE
27-Feb-2024 - 29-Feb-2024
The bacteriophage community is experiencing a period of renaissance of funding and clinical breakthroughs, with 2023 having been a pivotal year when the UK government injected £210m to tackle global antimicrobial resistance. As the only industry-led platform for phage drug developers, the 6th Bacteriophage Therapy Summit will return to Boston in 2024 to unite 90+ phage experts that will: Expedite Phage Discovery Through High-Throughput Screening and AI to Enhance Targeting and Specificity Bridge the Gap of Engineered, Natural, and Hybrid Phage to Expand Flexibility Navigate Regulatory Pathways of Phage to Ensure Successful Clinical Trials Broaden Phage's Therapeutic and Delivery Vehicle Potential Beyond AMR Date and Time: On Tue, 27 Feb 2024 09:00 - Thu, 29 Feb 2024 15:15
Bacteriophage Therapy Summit
With the EMA's guidance on the use of real world evidence in its regulatory decision-making, and federated learning networks that continue to support pharma, the integration of real world evidence into clinical research is transforming drug development. Following on from the 11th IMPACCT Real World Evidence Summit US, created-by biopharma-for biopharma, the IMPACCT Real World Evidence Summit Europe stands out as the only European industry-led meeting dedicated to the practical applications of real world evidence across all stages of clinical research from patient identification through to phase IV that will empower you to revolutionise your clinical research capabilities. Coming to Amsterdam in February 2024, the summit will gather biopharma for an unparalleled learning and networking oppo…
IMPACCT Real World Evidence Summit Europe

Where will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch markets like the UK, the EU4 and the US, but have you thought about other markets? Have you looked at the reimbursement requirements for rare disease products in the Nordic markets? Have you explored opportunities in growth markets, such as those in the Middle East and North Africa (MENA) region? This Rare Disease Day, our Global Market Access team will compare and contrast access opportunities and challenges for rare disease treatments in the differing markets of the Nordic and MENA regions, asking: what does this mean for your overarching market access strategy? Join us live at 1.00pm (GMT)/2.00pm (CET)/8.00am (EST) on Thursday 29th February…
Rare disease market access – Launching orphan drugs in secondary markets: the Nordic and MENA regions
05-Mar-2024 - 07-Mar-2024
GPCRs-targeted drug discovery continues to gain exponential momentum, with advances in screening tools, characterization of dynamic confirmations and basic GPCR biology, including orphan receptors. Coupled with numerous strategic collaboration and investment, the GPCR field is fuelling for the clinical progression of next-generation small molecules and biologics across a spectrum of indications and previously undrugged GPCR targets. Owing to this, the Annual GPCRs-Targeted Drug Discovery Summit returns for its 3rd year as the world's only and most comprehensive industry dedicated GPCR forum. Bringing two brand new specialized tracks of content (Target ID and Validation and Hit ID and Optimization), don't miss out on your ultimate chance to unite with 100+ GPCR experts devoted to accelerati…
GCPRs Targeted Drug Discovery Summit
With the cell and gene therapy industry surging, rapid advances in mRNA-based therapies, and the advent of DNA vaccines, the demand for quality DNA as a critical starting and therapeutic material has skyrocketed in recent years. The Inaugural DNA Process Development and Manufacturing Summit is the only forum solely dedicated to increasing plasmid and cell-free based DNA production while reducing costs, time, and ensuring regulatory compliance. Meet 80+ DNA production experts over 3 days packed with deep-dive workshops, data-led presentations, and dedicated discussion and networking sessions to address the most pressing challenges of producing DNA, brought together by our 18+ expert speakers from leading companies like Sanofi, Roche, Genentech, Pfizer and more. If you want to gain higher yi…
DNA Process Development and Manufacturing Summit | Boston, MA | March 5-7, 2024
We are delighted to welcome you to the 17th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2024) to be held on 6-9 March 2024 in Florence, Italy. We invite you to be a part of ATTD – the leading international forum – where clinicians, diabetes care providers, researchers, industries, start-up, investors, reimbursement authorities, regulators and people with diabetes, assemble with the goal to ameliorate the care of people with diabetes as the fastest possible pace. Presentations and discussions will be given by many distinguished professionals in the field and will include topics such as artificial intelligence-based decision support systems, glucose sensors, closed-loop systems, artificial pancreas, devices for diabetic prevention, new medications for…
ATTD 2024 - 17th International Conference on Advanced Technologies and Treatments for Diabetes
12-Mar-2024 - 15-Mar-2024
Antibody-drug conjugates are coming of age with a remarkable surge in recent times, which has marked a turning point in their development. Notable achievements include the ground-shaking triumph of ENHERTU, eye-popping investments like Pfizer's monumental $43 billion acquisition of Seagen, and the FDA's greenlight for ELAHERE. These milestones have transformed the ADC landscape, driving increased interest and investment in the field, which now has a preclinical and clinical arena dynamically evolving. As such, the 14th World ADC London returns next March. This will be the first opportunity in the new year to explore these monumental wins, reflect on ongoing challenges, and collaborate on innovative strategies to supercharge all stages of ADC development. Secure regulatory approvals and pos…
14th World ADC London 2024
The Annual Pharma Supply Chain & Security World Summit is back in London for the 6th time, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. The pharmaceutical supply chains are facing a significant challenge in the form of counterfeit drugs that are entering the supply chain from various points at different levels. Pharmaceutical companies that adopt an effective serialisation program have end-to-end visibility and traceability for all of their packaging, labelling, and distribution. This enables them to rapidly identify and quarantine counterfeit products. This helps to protect patients, consumers worldwide, brand equity, reputations and the company's revenue stream by ensuring compliance wit…
Pharma Supply Chain & Security World 2024
19-Mar-2024 - 21-Mar-2024
About Bioprocessing Summit Europe Bioprocessing Summit Europe brings together 750+ upstream, downstream, bioproduction, analytical and formulation professionals to advance the manufacture, quality and control of biological and genetic therapies, and new for 2024, Alternative Proteins such as Cultured Meat. This 3-day, 12 track meeting has quickly become a premier meeting in the European bioprocessing calendar and is regarded by many as &ldquo;the fastest growing bioprocessing meeting in Europe&rdquo; following record growth in 2023 &ndash; 500 to 700+ attendees &ndash; including a sold-out Exhibit Hall of 65 Solution Providers. We look forward to seeing you in Barcelona on 19-21 March 2024, with expanded content on downstream processing, smart and sustainable bioproduction,…
The 4ᵗʰ Wet AMD and Diabetic Eye Disease Drug Development Summit is returning to Boston this March to unite 70+ industry-based retinal vascular experts from the likes of Bayer, Boehringer Ingelheim, Genentech, Novartis and OcuTerra, at the only industry-dedicated forum to transform the potential of treatment of chronic, sight-threatening retinal vascular diseases to improve patient outcomes. Hear fresh perspectives from the new companies speaking at the 2024 meeting including Aviceda Therapeutics, Bayer, Boehringer Ingelheim, OcuTerra, Novartis, Genentech, and Adverum Biotechnologies and discover robust new content focusing on industry-specific topics such as new targets, in vivo and in vitro models, retinal imaging and clinical biomarkers and new modalities for retinal and choroidal neova…
4th Wet AMD and Diabetic Eye Disease Drug Development
Accelerate Your Insight of Mechanisms of Action, Cellular Pathways and Endosomal Escape to Gain Access to Tumor and Cell-Specific Targets Step into the 2nd Targeted Intracellular Delivery Summit, a thrilling exploration of cutting-edge advancements in drug delivery. This year, we redefine possibilities, venturing beyond traditional boundaries with a focus on cellular biology and intracellular mechanisms. Optimize drug delivery, overcome endosomal challenges, and expand therapies beyond the liver with in-depth case studies and a Pre-Conference Workshop Day. Gain insights into targeted cell interventions for cancer and autoimmune diseases, re-thinking innovative delivery platforms and strategies for cargo delivery into novel targets. Engage in transformative discussions and exclusive case st…
2nd Targeted Intracellular Delivery Summit
The last 12 months have highlighted key milestones in European biopharma investment– from GSK injecting €1 million into a 15-building biotech campus in Stevenage, to AstraZeneca investing £1 billion into a new R AND D and Corporate HQ. As the pressure to expand and continue pipeline progression within a scattered and distributed market, there has never been a better time to know how to navigate unknown waters. Emulating the 2023 success, the Lab Asset and Facility Management in Pharma Europe returns for the second year running. This expert-led summit is solely dedicated to imparting expert knowledge with the goal of expediting operational excellence in laboratories across Europe. Join 80+ senior lab, R AND D operations, lab workplace strategy, lab equipment, and asset leaders from the like…
2nd Lab Asset and Facility Management in Pharma Europe